Jacob Asset Management of New York’s Cytosorbents Corp CTSO Stock Holding History

Jacob Asset Management of New York’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$372K	Sell	197,940 -40,000	-17%	-$115K	0.52%	48
2023 Q2	$854K	Hold	237,940	–	–	0.96%	39
2023 Q1	$802K	Sell	237,940 -10,000	-4%	-$30K	0.94%	35
2022 Q4	$384K	Sell	247,940 -5,060	-2%	-$7.51K	0.47%	48
2022 Q3	$344K	Buy	253,000 +70,000	+38%	+$137K	0.37%	47
2022 Q2	$401K	Sell	183,000 -2,000	-1%	-$4.59K	0.41%	47
2022 Q1	$590K	Hold	185,000	–	–	0.36%	52
2021 Q4	$775K	Hold	185,000	–	–	0.35%	54
2021 Q3	$1.5M	Hold	185,000	–	–	0.55%	45
2021 Q2	$1.4M	Buy	185,000 +60,000	+48%	+$506K	0.46%	52
2021 Q1	$1.08M	Buy	+125,000	New	+$1.19M	0.42%	55

Other funds holding CTSO

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Jacob Asset Management of New York's CTSO Position: Q3 2023 in Review

Jacob Asset Management of New York reduced its Cytosorbents Corp (CTSO) stake by 17% in Q3 2023, selling an estimated $115K and leaving 197,940 shares worth $372K. The position accounts for 0.52% of the portfolio, ranked #48.

Jacob Asset Management of New York first reported a position in CTSO in Q1 2021 and has held it in 11 quarters since. The position peaked at $1.5M in Q3 2021. 53 funds tracked by Wall St. Rank hold CTSO as of Q3 2023.

Jacob Asset Management of New York held 197,940 shares of Cytosorbents Corp worth $372K as of Q3 2023.
Jacob Asset Management of New York sold 40,000 Cytosorbents Corp shares in Q3 2023, an estimated $115K.
Cytosorbents Corp made up 0.52% of Jacob Asset Management of New York's portfolio in Q3 2023, its #48 holding.
Jacob Asset Management of New York first reported a position in Cytosorbents Corp in Q1 2021 and has held it in 11 quarters since.
Jacob Asset Management of New York's Cytosorbents Corp position peaked at $1.5M in Q3 2021.
53 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2023.

Based on Jacob Asset Management of New York's 13F filing for Q3 2023, filed 1 Nov 2023.